Alzheimer’s Disease: Risk Tests and the Medical Record

Article type: Article Commentary

Authors: Zallen, Doris T.^{; *}

Affiliations: Department of Science, Technology, and Society, Virginia Tech, Blacksburg, VA, USA

Correspondence: [*] Correspondence to: Doris T. Zallen, 904 Mason Drive, Blacksburg, VA 24060, USA. Tel.: +1 540 231 4216/ 540 552 9171; E-mail: [email protected].

Abstract: Although the medical record is the centerpiece of modern medical care, its usefulness is diminished by the reluctance of people to disclose important health information, such as a higher risk for Alzheimer’s disease, to their doctors. Steps should be taken now to ensure that the medical record, the repository of one’s health information, can continue to serve the needs of the medical community and of patients.

Keywords: APOE, biomarkers, jurisprudence, medical records electronic

DOI: 10.3233/JAD-220584

Journal: Journal of Alzheimer's Disease, vol. 90, no. 3, pp. 997-999, 2022